Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leon Su

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Immunity|November 22, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Cytotherapy|September 29, 2025
Quality indicators for cell collections for immune effector cell and gene therapy: recommendations from the American Society for ApheresisNicole A Aqui, Patricia A Shi, Yara A Park, et al.
Nature|October 22, 2020
Immune receptor inhibition through enforced phosphatase recruitmentRicardo A Fernandes, Leon Su, Yoko Nishiga, et al.
Immunity|December 13, 2023
Stat5 opposes the transcription factor Tox and rewires exhausted CD8<sup>+</sup> T cells toward durable effector-like states during chronic antigen exposureJean-Christophe Beltra, Mohamed S Abdel-Hakeem, Sasikanth Manne, et al.
Blood Immunology & Cellular Therapy|April 17, 2026
Viral vector-free generation of orthogonal IL-2-responsive CAR T cells through gene editing of IL-2 and its receptorQian Zhang, Yihao Wu, Jingyi Yang, et al.
Science (New York, N.Y.)|February 19, 2026
Rewiring STAT signaling from the cell surface with Trikine immunotherapeuticsGrayson E Rodriguez, Yang Zhao, Yoko Nishiga, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Immunity|November 22, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Cytotherapy|September 29, 2025
Quality indicators for cell collections for immune effector cell and gene therapy: recommendations from the American Society for ApheresisNicole A Aqui, Patricia A Shi, Yara A Park, et al.
Nature|October 22, 2020
Immune receptor inhibition through enforced phosphatase recruitmentRicardo A Fernandes, Leon Su, Yoko Nishiga, et al.
Immunity|December 13, 2023
Stat5 opposes the transcription factor Tox and rewires exhausted CD8<sup>+</sup> T cells toward durable effector-like states during chronic antigen exposureJean-Christophe Beltra, Mohamed S Abdel-Hakeem, Sasikanth Manne, et al.
Blood Immunology & Cellular Therapy|April 17, 2026
Viral vector-free generation of orthogonal IL-2-responsive CAR T cells through gene editing of IL-2 and its receptorQian Zhang, Yihao Wu, Jingyi Yang, et al.
Science (New York, N.Y.)|February 19, 2026
Rewiring STAT signaling from the cell surface with Trikine immunotherapeuticsGrayson E Rodriguez, Yang Zhao, Yoko Nishiga, et al.
Pageof 6